PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 214 filers reported holding PTC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,395,405 | +758.5% | 106,890 | +1457.9% | 0.00% | – |
Q2 2023 | $279,037 | +19104.2% | 6,861 | -77.1% | 0.00% | -100.0% |
Q1 2023 | $1,453 | -87.3% | 30,000 | -90.0% | 0.00% | -83.3% |
Q4 2022 | $11,418 | -99.9% | 299,133 | -32.2% | 0.01% | -53.8% |
Q3 2022 | $22,156,000 | +5425.2% | 441,353 | +4313.5% | 0.01% | – |
Q2 2022 | $401,000 | -61.1% | 10,000 | -61.3% | 0.00% | -100.0% |
Q4 2021 | $1,030,000 | +122.5% | 25,854 | +107.9% | 0.00% | – |
Q3 2021 | $463,000 | +92.1% | 12,436 | +118.1% | 0.00% | – |
Q2 2021 | $241,000 | -96.6% | 5,701 | -96.2% | 0.00% | -100.0% |
Q1 2021 | $7,139,000 | +657.1% | 150,778 | +876.1% | 0.01% | +400.0% |
Q4 2020 | $943,000 | -46.7% | 15,447 | -61.1% | 0.00% | -75.0% |
Q1 2020 | $1,770,000 | -53.8% | 39,682 | -50.3% | 0.00% | -20.0% |
Q4 2019 | $3,835,000 | -43.0% | 79,841 | -59.9% | 0.01% | -54.5% |
Q3 2019 | $6,726,000 | -87.9% | 198,879 | -83.9% | 0.01% | -86.7% |
Q2 2019 | $55,500,000 | +174.1% | 1,233,328 | +129.2% | 0.08% | +176.7% |
Q1 2019 | $20,250,000 | +261.3% | 538,001 | +229.4% | 0.03% | +233.3% |
Q4 2018 | $5,605,000 | -65.7% | 163,311 | -53.0% | 0.01% | -55.0% |
Q3 2018 | $16,344,000 | +14.3% | 347,745 | -18.0% | 0.02% | +5.3% |
Q2 2018 | $14,298,000 | -22.0% | 423,906 | -37.4% | 0.02% | -20.8% |
Q1 2018 | $18,333,000 | +98.0% | 677,501 | +22.0% | 0.02% | +84.6% |
Q4 2017 | $9,261,000 | +77.6% | 555,205 | +113.0% | 0.01% | +62.5% |
Q3 2017 | $5,215,000 | -29.2% | 260,633 | -65.2% | 0.01% | -38.5% |
Q1 2017 | $7,361,000 | -56.1% | 748,105 | -51.3% | 0.01% | -62.9% |
Q4 2016 | $16,753,000 | +389.0% | 1,535,567 | +527.9% | 0.04% | +483.3% |
Q3 2016 | $3,426,000 | +838.6% | 244,537 | +370.2% | 0.01% | +500.0% |
Q2 2016 | $365,000 | -89.8% | 52,002 | -90.6% | 0.00% | -88.9% |
Q1 2016 | $3,568,000 | +120.2% | 553,961 | +1007.9% | 0.01% | +200.0% |
Q4 2015 | $1,620,000 | -88.3% | 50,000 | -90.4% | 0.00% | -88.9% |
Q3 2015 | $13,868,000 | -32.4% | 519,419 | +21.8% | 0.03% | -30.8% |
Q2 2015 | $20,525,000 | +574.5% | 426,441 | +752.9% | 0.04% | +550.0% |
Q1 2015 | $3,043,000 | +89.5% | 50,000 | +61.1% | 0.01% | +100.0% |
Q4 2014 | $1,606,000 | -89.6% | 31,030 | -91.2% | 0.00% | -92.3% |
Q3 2014 | $15,480,000 | +32.5% | 351,734 | -21.3% | 0.04% | +21.9% |
Q2 2014 | $11,681,000 | – | 446,881 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 160,372 | $7,594,000 | 6.15% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 408,000 | $19,319,000 | 5.11% |
RTW INVESTMENTS, LP | 5,293,966 | $250,669,000 | 3.91% |
GEORGE KAISER FAMILY FOUNDATION | 72,105 | $9,925,000 | 2.07% |
SECTORAL ASSET MANAGEMENT INC | 504,928 | $23,908,000 | 1.81% |
Redwood Investments, LLC | 385,014 | $18,230,000 | 1.60% |
ARMISTICE CAPITAL, LLC | 1,396,000 | $66,101,000 | 1.52% |
Integral Health Asset Management, LLC | 100,100 | $4,740,000 | 1.35% |
Sofinnova Investments, Inc. | 466,840 | $22,105,000 | 1.33% |
Chubb Ltd | 8,180 | $387,000 | 1.10% |